Top Nutrition Coaching is fully dedicated to providing its readers with transparent, accurate, and compassionate information that applies to individuals from every demographic. Our nutritionists adhere to specific guidelines when creating content to ensure that all published materials are most advantageous to our readers. Top Nutrition Coaching has a no-tolerance policy regarding plagiarism.
All materials published by Top Nutrition Coaching adhere to the criteria outlined below:
- When possible, Top Nutrition Coaching only uses primary sources. Only peer-reviewed journals and government and state sites will be used if primary sources are unavailable.
- Our team reviews every article on the Top Nutrition Coaching site on a periodic basis. Our regular review process ensures that we constantly communicate the most up-to-date information about nutrition, health, and wellness.
- All of our content will be thorough and factual but also approachable. Our goal is to help readers learn about nutrition, not to confuse them.
- All of our content is verified by nutritionists and dietitians with certifications and advanced degrees. Every article will include a registered nutritionist or dietitian’s byline.
- None of our content will include false promises or guarantees. Our number one priority is supporting our audience and their health – their needs come first.
Mounjaro vs. Zepbound: Differences, Similarities, and How Nutrition Fits It
Mounjaro and Zepbound share the same active ingredient, but their FDA-approved uses, eligibility, and insurance coverage differ. Here’s how they compare, and how nutrition supports treatment on either one.
Key Takeaways
- Same medication: Mounjaro and Zepbound both contain tirzepatide and are made by Eli Lilly.
- Different FDA approvals: Mounjaro is approved for type 2 diabetes, while Zepbound is approved for long-term weight management and moderate-to-severe obstructive sleep apnea in adults with obesity.
- Coverage depends on the use: Approved uses affect who qualifies for each medication and how insurance covers it.
- Shared dosing and side effects: Both are weekly injections with the same dose range, side effects, and safety warnings.
- Nutrition matters on either: Eating enough protein and nutrient-rich foods can help manage side effects and preserve muscle — see if your insurance covers a dietitian to get support.
Mounjaro vs. Zepbound: Same active ingredient, same manufacturer… What could possibly be different besides their names?
I won’t beat around the bush: The biggest difference is what the FDA has approved them to treat. Those approved uses affect who qualifies for each medication and whether insurance will cover it.
In this article, we’ll break down their similarities, differences, and the role of nutrition. Because regardless of which medication you’re prescribed, healthy eating habits are an important part of treatment.
Is Mounjaro the Same as Zepbound?
Mounjaro and Zepbound contain the exact same active ingredient, tirzepatide, and both are made by Eli Lilly. The main difference isn’t the medication itself, but what each brand is FDA-approved to treat.
Mounjaro is approved to manage blood sugar in people with type 2 diabetes and to reduce the risk of major cardiovascular events in certain high-risk adults with type 2 diabetes. Zepbound, on the other hand, is approved for long-term weight management in eligible adults and to treat moderate-to-severe obstructive sleep apnea in adults with obesity.
Although they contain the same drug, your prescriber will help decide which option best fits your health needs.
How Tirzepatide Works
Both medications work the same way, so understanding how Mounjaro works also helps explain Zepbound.
Tirzepatide mimics the actions of two hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). It helps regulate insulin and glucagon to improve blood sugar control, slows gastric emptying, and acts on the brain to reduce appetite and food cravings. These effects support blood sugar management and weight loss.
This dual action is also a key difference between semaglutide and tirzepatide. While semaglutide solely targets GLP-1, tirzepatide acts on both hormone pathways.
Key Differences Between Mounjaro and Zepbound
Although Mounjaro and Zepbound contain the same medication, their FDA-approved uses, eligibility requirements, and insurance coverage differ.
FDA-Approved Uses
According to the official Mounjaro Prescribing Information, Mounjaro is FDA-approved to help manage blood sugar in adults and children ages 10 and older with type 2 diabetes. In August 2026, it received approval to reduce the risk of major cardiovascular events — such as heart attack and stroke — in certain high-risk adults with type 2 diabetes.
One important distinction: While people taking Mounjaro may lose weight, weight loss isn’t an FDA-approved use of Mounjaro.
Zepbound is FDA-approved for long-term weight management in eligible adults. In 2024, it became the first medication approved to treat moderate-to-severe obstructive sleep apnea in adults with obesity.
Who Qualifies for Mounjaro vs. Zepbound
Mounjaro is prescribed to adults and children ages 10 and older with type 2 diabetes.
Zepbound is an option for adults with obesity (a body mass index [BMI] of 30 or higher) or overweight (a BMI of 27 or higher) with at least one weight-related health condition — such as high blood pressure or high cholesterol. Zepbound may also be prescribed for adults with obesity who have moderate-to-severe obstructive sleep apnea. These weight-related criteria align with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) guidance on prescription medications for weight management.
If you’re considering GLP-1s for weight loss, your prescriber can help determine whether Zepbound is appropriate based on your medical history and treatment goals.
Insurance Coverage and Cost
Mounjaro is often covered under diabetes medication benefits, although coverage depends on your plan and diagnosis.
Zepbound coverage can be trickier, especially for weight management. Some plans exclude weight-loss medications but may cover Zepbound when it’s prescribed for obstructive sleep apnea. That’s why it’s worth checking which GLP-1 medications your insurance covers for weight loss.
Even if your plan covers either medication, you may need prior authorization, meaning your prescriber must submit information showing you meet your insurer’s requirements.
Without insurance, these medications can be expensive, but there may be ways to lower the cost. For example, the cost of Zepbound varies by dose and how you purchase it, and manufacturer savings programs and self-pay options may make it more affordable.
Before starting treatment, confirm your coverage requirements and expected out-of-pocket costs.
What Mounjaro and Zepbound Have in Common
Because Mounjaro and Zepbound share the same active ingredient, they have several similarities beyond how they work.
Both are injected under the skin once a week, starting at 2.5 milligrams (mg) and gradually increasing to a maintenance dose as needed, up to 15 mg weekly. Zepbound follows the same dose escalation schedule as Mounjaro, though the right dose depends on your treatment needs.
Both are available as single-dose pens and vials, and Mounjaro also comes in a multi-dose KwikPen, depending on availability. They also share similar side effects and safety warnings, including an FDA boxed warning about thyroid tumors observed in rodents. (We’ll cover this in detail in the upcoming sections.)
Effectiveness for Weight Loss and Blood Sugar
For blood sugar management, the SURPASS-2 trial found that tirzepatide reduced A1C, a measure of average blood sugar over roughly three months, by about 2.0 to 2.3 percentage points over 40 weeks in adults with type 2 diabetes.
In the SURMOUNT-1 trial, adults with obesity or overweight without diabetes lost about 15% to 21% of their body weight after 72 weeks, depending on the dose. In comparison, those taking a placebo lost about 3%. Both groups also received regular counseling on healthy eating, reducing calorie intake, and getting at least 150 minutes of physical activity per week.
Keep in mind that results vary from person to person, and weight loss doesn’t always follow a straight downward path. If you’re not losing weight on Mounjaro or Zepbound as expected, factors like your dose, how long you’ve been taking the medication, and your eating habits may play a role.
Side Effects and Safety Considerations
Zepbound and Mounjaro side effects are similar since they contain the same medication. The most common include nausea, diarrhea, constipation, and vomiting. Symptoms are often more noticeable when you first start treatment or increase your dose, but they generally improve as your body adjusts.
Both medications carry an FDA boxed warning about thyroid C-cell tumors observed in rodents. It’s unknown whether this risk applies to humans. Neither medication should be used if you or a family member has had medullary thyroid carcinoma (MTC), a type of thyroid cancer, or if you have multiple endocrine neoplasia syndrome type 2 (MEN2).
Other serious risks include pancreatitis (inflammation of the pancreas), gallbladder problems, and kidney injury caused by dehydration. Because tirzepatide slows how quickly food leaves your stomach, it may also increase the risk of stomach contents entering your lungs during general anesthesia or deep sedation. Be sure to tell your medical team you're taking tirzepatide before any planned surgery or procedure.
Know when to seek help:
- Call your prescriber if vomiting or diarrhea doesn’t subside, you’re having trouble drinking enough fluids, or you develop pain in your upper abdomen.
- Seek immediate medical care if you have severe, persistent abdominal pain, especially if it spreads to your back, or signs of a serious allergic reaction, such as difficulty breathing or swelling of your face or throat.
It’s also important to ask your prescriber about medication interactions or dose changes rather than adjusting treatment yourself.
Eating to Ease GI Side Effects
If you’re dealing with nausea, constipation, or other digestive symptoms, a few dietary changes may help:
- Eat smaller meals: Eat smaller portions more often throughout the day instead of three large meals.
- Eat slowly: Take small bites, chew your food thoroughly, and stop when you feel comfortably full. Try slowing down enough to sing your ABCs while you chew!
- Limit greasy foods: Try baked, grilled, or steamed foods instead of fried or high-fat meals.
- Stay hydrated: Keep a water bottle handy and sip throughout the day. If you’re losing fluids from vomiting or diarrhea, ask your clinician whether an oral rehydration solution might help.
- Add fiber gradually: If you’re constipated, slowly increase fiber-rich foods — like oats, berries, pears, beans, lentils, chia seeds, and vegetables — along with plenty of fluids.
If symptoms make it difficult to eat or drink enough, contact your prescriber.
Nutrition While Taking Tirzepatide
Mounjaro and Zepbound can significantly reduce your appetite, which can help with weight loss but also make it harder to get enough protein and other important nutrients. Here are a few ways to meet your nutritional needs while taking tirzepatide:
- Prioritize protein: Include foods like eggs, Greek yogurt, chicken, fish, tofu, or beans at meals to help prevent muscle loss on GLP-1s. I also strongly recommend strength training at least twice a week!
- Make smaller meals count: When you’re eating less, choose nutrient-rich foods like fruits, vegetables, whole grains, and healthy fats. A balanced GLP-1 diet can help you meet your nutritional needs without forcing large portions.
- Build habits you can maintain: Try to eat regular, balanced meals and find physical activities you enjoy (or dislike the least!). These habits can help support your health while taking tirzepatide and if you eventually stop treatment.
A registered dietitian can help you plan meals when your appetite is low, manage digestive side effects, and ensure you’re getting enough nutrients. They can also work with your prescriber to support your long-term health goals.
Is Mounjaro or Zepbound Right for You?
Choosing between Mounjaro and Zepbound depends on what you’re treating, whether you meet the eligibility requirements, and what your insurance covers.
Mounjaro is generally prescribed for type 2 diabetes, while Zepbound is approved for weight management in eligible adults and for moderate-to-severe obstructive sleep apnea in adults with obesity. Your prescriber will review your medical history, treatment goals, and insurance options to determine which medication is appropriate.
Whichever medication you’re prescribed, managing side effects and getting enough nutrients can be challenging, especially when your appetite is low. Top Nutrition Coaching’s GLP-1 and RD program connects you with a licensed registered dietitian who can help you navigate these challenges and build healthy habits that last — with between-session messaging when questions come up.
And good news! Many insurance plans also cover nutrition counseling. To get started, check your insurance coverage for a dietitian to see what benefits may be available to you.
FAQs
Can you switch from Mounjaro to Zepbound?
Yes, you may be able to switch from Mounjaro to Zepbound since both contain tirzepatide. However, insurance coverage may differ since Mounjaro is FDA-approved for type 2 diabetes, while Zepbound is approved for weight management and certain cases of sleep apnea. Your prescriber can help you decide whether switching is right for you.
Which is better for weight loss, Mounjaro or Zepbound?
Neither is expected to work better for weight loss at the same dose because both contain tirzepatide. The main difference is that Zepbound is FDA-approved for weight management, while Mounjaro is approved for type 2 diabetes. Which one is appropriate for you depends on your health needs, eligibility, and insurance coverage.
Can you get Zepbound if you have type 2 diabetes?
Yes, you can be prescribed Zepbound for weight management even if you have type 2 diabetes. You may qualify if your BMI is 30 or higher, or 27 or higher with a weight-related condition, such as type 2 diabetes. However, your prescriber may recommend Mounjaro instead because it’s approved for managing type 2 diabetes.
Why is Zepbound sometimes cheaper than Mounjaro?
Zepbound may be cheaper if you’re paying out of pocket because Eli Lilly offers self-pay options that can cost less than Mounjaro’s full retail price. However, Mounjaro may cost less if your insurance covers it for type 2 diabetes. Ultimately, your actual cost depends on your insurance, dose, and available savings programs.
Do you lose muscle on Mounjaro or Zepbound?
Yes, some muscle loss can occur as you lose weight on Mounjaro or Zepbound. In a SURMOUNT-1 substudy, about 25% of the weight lost with tirzepatide came from lean mass, which includes muscle but also water and other tissues. Eating enough protein and strength training at least twice a week can help preserve muscle during weight loss.
What happens if you stop taking tirzepatide?
After stopping tirzepatide, your appetite may increase, and you may regain some weight. In the SURMOUNT-4 trial, participants who stopped treatment regained an average of 14% of their body weight over the following 52 weeks. Blood sugar and other health improvements may also reverse, so talk to your prescriber about a plan before stopping treatment.
